"Health care leader whose mission is to keep you healthy. Under-one-roof convenience, 24-hour advice nurse, and online access to manage your health anytime. We are here to care for you virtually or in-person. Start by connecting with your care team online (visit our website) or by calling the Appointment and Advice Contact Center at 303-338-4545 or 1-800-218-1059 (TTY 711)."

During the past decade, Kaiser Permanente of Colorado conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente of Colorado" #1 sponsor was "Kaiser Permanente" with 8 trials, followed by "Hoffmann-La Roche" with 1 trials sponsored, "Johns Hopkins University" with 1 trials sponsored, "Northwestern University" with 1 trials sponsored and "Novartis Vaccines" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente of Colorado" #1 collaborator was "Kaiser Permanente" with 3 trials as a collaborator, "American Lung Association" with 1 trials as a collaborator, "Duke University" with 1 trials as a collaborator, "Emory University" with 1 trials as a collaborator and "Garfield Memorial Fund" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente of Colorado" are "Dementia" (2 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (2 trials), "Acquired Immunodeficiency Syndrome" (1 trials), "Adolescent Substance Use" (1 trials) and "Alzheimer Disease and Related Dementias" (1 trials). Many other conditions were trialed in "Kaiser Permanente of Colorado" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente of Colorado" are "Behavioral" (10 trials), "Other" (4 trials), "Biological" (1 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alma" (1 trials), "An Enhanced Reminder" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials), "Education only" (1 trials) and "Educational Materials - Patient & Clinician" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente of Colorado" are 13 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Kaiser Permanente of Colorado". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Kaiser Permanente of Colorado, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente of Colorado, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 11 trials that are defined as “Not Applicable".